Anne B. Cropp, Pharm.D, BCAP
Chief Scientific Officer Early Access Care LLC
Dr. Anne Cropp is Chief Scientific Officer of Early Access Care LLC, a healthcare company focused on facilitating all stakeholders involved in the review and approval of Expanded Access and Compassionate Use requests for investigational drugs. Prior to founding Early Access Care, Anne was Vice President in the Global Product Development Group at Pfizer Inc. Anne has twenty-five years of experience in the biopharmaceutical industry marked by achievements in innovation and successful development of new drug products. Anne has partnered extensively with the Regulatory Strategy groups across all therapeutic areas and has a deep understanding of FDA expectations yet vision for opportunity for flexibility in program development that will lead to successful registration.
Anne has been responsible for the strategic planning, development and execution of investigational drugs across a wide spectrum of disease areas in adult and pediatric patients. She has developed and executed very large and mid-sized programs in disease areas that span Alzheimer’s disease, heart failure, hypercholesterolemia, hypertension, Type I and II Diabetes Mellitus and Vascular Surgery. She has an advanced understanding and direct expertise in Advisory Boards, Data Monitoring Committees, Endpoint Adjudication, Interim Analyses, and Safety Committees.